Position in CYDY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$10,800
-$1,350 QoQ
Shares Held
45,001
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 6 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CYDY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Williams Jones Wealth Management, LLC. holds $1,244,398 across 7 Biotechnology names. CYDY ranks #5 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,169 | $580,677 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
742 | $462,666 | |
| 3 | LCTX |
Lineage Cell Therapeutics, Inc.
|
101,300 | $132,703 | |
| 4 | ATAI |
AtaiBeckley Inc.
|
10,000 | $52,700 | |
| 5 | CYDY |
CytoDyn Inc.
This page
|
45,001 | $10,800 | |
| 6 | NWBO |
Northwest Biotherapeutics Inc
|
25,000 | $4,750 | |
| 7 | PKTX |
ProtoKinetix, Inc.
|
20,000 | $102 |
All Filings in CYDY
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,800 | 45,001 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $12,150 | 45,001 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $12,600 | 45,001 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $11,700 | 45,001 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $12,150 | 45,001 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $10,350 | 45,001 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,950 | 45,001 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,200 | 45,001 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,500 | 25,001 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $3,040 | 19,001 | Shares | Sole | 2024-05-07 | |
| No filing history on record for this holder in this stock. | ||||||